HLA-haploidentical hematopoietic stem cell transplantation with low-dose thymoglobulin GVHD prophylaxis for an adult T cell leukemia/lymphoma patient treated with pretransplant mogamulizumab

Ann Hematol. 2017 Feb;96(2):327-328. doi: 10.1007/s00277-016-2856-y. Epub 2016 Oct 21.

Authors

Makoto Hirosawa¹, Takehiro Higashi¹, Atsushi Iwashige¹, Takahiro Yamaguchi¹, Junichi Tsukada²

Affiliations

¹ Hematology, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi, Kitakyushu, 807-8556, Japan.
² Hematology, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi, Kitakyushu, 807-8556, Japan. jtsukada@med.uoeh-u.ac.jp.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antibodies, Monoclonal, Humanized / administration & dosage*
Antilymphocyte Serum / administration & dosage*
Graft vs Host Disease / prevention & control*
Hematopoietic Stem Cell Transplantation / adverse effects
Hematopoietic Stem Cell Transplantation / methods*
Humans
Leukemia-Lymphoma, Adult T-Cell / diagnosis
Leukemia-Lymphoma, Adult T-Cell / therapy*
Male
Pre-Exposure Prophylaxis / methods
Transplantation Conditioning / adverse effects
Transplantation Conditioning / methods*
Transplantation, Homologous / adverse effects
Transplantation, Homologous / methods

Substances

Antibodies, Monoclonal, Humanized
Antilymphocyte Serum
thymoglobulin
mogamulizumab